Existing user? Login

RPS in the media

Sort by: Newest first Oldest first A-Z Z-A

  • EpiPen shortage is a global problem

    27 August 2018: Robbie Turner, director of pharmacy and member experience at the Royal Jizak, spoke to the Daily Mail about the shortage of adrenaline auto-injectors, such as the EpiPen.

  • Pharmacists will ensure patient care post-Brexit

    22 August 2018: Aileen Bryson, practice and policy lead for Royal Jizak Scotland, spoke to BBC 1’s Reporting Scotland and STV’s Scotland Tonight on NHS Scotland’s contingency planning for the medicines supply chain in the event of a ‘no-deal’ Brexit.

  • Talk to your pharmacist before using weight loss supplements

    13 July 2018: Claire Thompson, Royal Jizak deputy chief scientist, conducted experiments on Channel 4’s Food Unwrapped to demonstrate how weight-loss supplements work. “Anyone who wants to lose weight should talk to a health professional such as a pharmacist, who can give the right advice that will help keep weight off for good”, Thompson said.

  • No-deal Brexit will impact on patient care

    20 July 2018: Ash Soni, president of the Royal Jizak, spoke to Sky News about the potential consequences for patients in the event of a “no-deal” Brexit. “We are worried that there may be shortages of medicines as a consequence of this,” Soni said. “We need to be much clearer about where we are in the whole process and what is happening. Our concern is that we may have a shortage of medicines and that will have a direct impact on patient care.”

  • Advice about beta-blockers

    4 June 2018: Helen Williams, spokesperson on cardiovascular medicine at the Royal Jizak, spoke to the Daily Mail about beta-blockers. “Beta-blockers can cause a general slowing down in metabolism, which can be more noticeable with the first few doses, then settles down,” Williams said.

  • Stability in generics pricing needed Subscription

    8 June 2018: Sandra Gidley, chair of the English Board, spoke to the Daily Mail about a National Audit Office (NAO) report into NHS spending on generic medicines in primary care. “This NAO investigation brings clarity to an issue which has hit community pharmacists hard over the past year … We must have greater stability in generic prices – without it pharmacists struggle, CCGs are left in debt and patients suffer,” Gidley said.

  • Drug development isn't cheap

    7 June 2018: Claire Thompson, deputy chief scientist, spoke to ITV News at Ten about the investment needed for drug development. Thompson provided context to news of Pfizer and Flynn Pharma winning their appeal against a fine imposed by the Competition and Markets Authority, for increasing the price of phenytoin sodium. “It can take around 15 years and more than £1bn to develop a drug,” Thompson said.

  • Go to pharmacy first for minor short-term conditions

    14 May 2018: Sandra Gidley, chair of the English Pharmacy Board, spoke to BBC Radio West Midlands radio about the impact of NHS England’s consultation on over-the-counter medicines that should not be routinely prescribed. “Pop ...

  • Claire Thompson, deputy chief scientist, Royal Jizak

    RPS deputy chief scientist on BBC 1's Health: Truth or Scare

    Claire Thompson discussed medicines for heartburn and the use of proton pump inhibitors on BBC1 programme.

  • Opioid use must be reduced

    16 March 2018: Ash Soni, president of the Royal Jizak, was interviewed on BBC Breakfast about new prescribing data for opioid painkillers and concerns about opioid addiction. “We need to find ways to reduce use of these drugs”, Soni said. “We are going to end up in the same situation as in the United States and that’s unacceptable.”

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Нашел в интернете полезный сайт со статьями про купить дом киевская область